|
|
||||||||
a Department of Epidemiology and Preventive Medicine, Monash University, Victoria
e Department of Surgery, Monash University, Victoria
b Department of Cardiothoracic Surgery, The Royal Melbourne Hospital, Melbourne, Australia
c Monash Medical Centre, Melbourne, Australia
d St. Vincent's Hospital, Melbourne, Australia
f Geelong Hospital, Victoria, Australia
g Alfred Hospital, Victoria, Australia
h Austin Hospital, Victoria, Australia
Accepted for publication February 3, 2009.
* Address correspondence to Dr Yap, Department of Cardiothoracic Surgery, The Royal Melbourne Hospital, Parkville, Victoria, 3050, Australia (Email: cheng-hon.yap{at}mh.org.au).
Background: Reoperative coronary artery bypass grafting (redo CABG) shows improving outcomes, but with varying degrees of improvement. We assessed contemporary outcomes after redo CABG to determine if redo status is still a risk factor for early postoperative complications and midterm survival.
Methods: Isolated CABG procedures (June 1, 2001 to May 31, 2008) within the Australasian Society of Cardiac and Thoracic Surgeons Cardiac Surgery Database were included. Redo status as a predictor for early outcomes was assessed with logistic regression analysis. Midterm survival was determined from the National Death Index. Effect of redo status on midterm survival was assessed using a Cox proportional hazards model.
Results: Inclusion criteria were met by 13,436 patients, and 458 (3.4%) underwent redo CABG. Operative mortality was 4.8% for redo CABG and 1.8% for first-time CABG (p < 0.001). After adjustment, redo status remained a predictor for operative mortality (odds ratio [OR], 2.1; 95% confidence interval [CI], 1.3 to 3.6), myocardial infarction (OR, 2.8; 95% CI, 1.6 to 6.0), and prolonged ventilation (OR, 1.5; 95% CI, 1.1 to 2.0). Unadjusted survival was lower for the redo CABG group vs the first-time CABG group at up to 6 years (p = 0.01, log-rank test. After adjusting for differences in patient variables, redo status was not a predictor of midterm survival (OR, 1.03; 95% CI, 0.78 to 1.35; p = 0.85).
Conclusions: Early postoperative outcomes of redo CABG are encouraging. Midterm survival is excellent; however, redo remains a significant risk factor for operative mortality in contemporary practice.
Related Article
Ann. Thorac. Surg. 2009 87: 1391.
This article has been cited by other articles:
![]() |
A. Tector Invited commentary. Ann. Thorac. Surg., May 1, 2009; 87(5): 1391 - 1391. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |